Our pulmonologists lead a medical team that is focused on improving the lives of people with lung diseases.
At NYU Langone’s Bronchiectasis and Cystic Fibrosis Program, our healthcare team uses its dedication, experience, and research know-how to provide treatments that can improve the lives and lifespans of people who have chronic lung ailments.
Bronchiectasis, cystic fibrosis, and nontuberculous mycobacterial (NTM) infections affect the lungs’ ability to clear mucus from airways. This buildup of fluid affects lung function and increases a person’s chance of infection.
The Bronchiectasis and Cystic Fibrosis Program brings together a team of pulmonologists, gastroenterologists, infectious disease specialists, otolaryngologists, physiatrists, respiratory therapists, and physical therapists who specialize in chest care to create a treatment plan that best meets the needs of each patient.
Our team is also committed to increasing education about these conditions. We host a patient education program on bronchiectasis and NTM infections that is aimed at helping patients better understand the condition and the treatment options available to them.
NYU Langone is a nationally recognized referral center for the treatment of people with bronchiectasis and cystic fibrosis. Since 2010, our physicians have treated more than 400 patients with these conditions, making us one of the leading care centers in the country. The program received full accreditation in 2014 by the Cystic Fibrosis Foundation.
Research in Bronchiectasis and Cystic Fibrosis
We are also committed to researching bronchiectasis, cystic fibrosis, and NTM. We have a dedicated research team and are involved in clinical, translational, and basic research. We participate in the national research registries and have several clinical trials available to patients.
More About Our Program
Our physicians are leaders in the management of bronchiectasis, cystic fibrosis, and nontuberculous mycobacteria and are actively involved in research initiatives to better understand these conditions and develop new therapies.Meet Our Doctors